Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
NCT01694212 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2017-04-20
Summary
Diabetes has many negative effects on patients' general health. Among many other consequences it speeds up the cataract formation and that is why diabetic patients need cataract surgery very often. The known side effect of cataract surgery even in otherwise healthy patients is postoperative edema of the back of the eye (what causes decrease of vision), which has greater incidence especially in patients who have diabetic eye problems. The cause of that might be the intraocular inflammation which was previously demonstrated to be significantly more prominent in patients with untreated diabetic eye problems. Therefore we will examine if the 7 day use of anti-inflammatory eye drops prior to the cataract surgery prevent the formation of the edema of the back of the eye.
Conditions
- Macular Edema
- Cataract
- Diabetic Retinopathy
Interventions
- DRUG
-
Perioperative Diclofenac eye-drops administration
- DRUG
Sponsors & Collaborators
-
Clinical Hospital Center, Split
collaborator OTHER -
University of Zagreb
collaborator OTHER -
Eye Clinic Medic Zuljan Jukic
lead OTHER
Principal Investigators
-
Ljubo Znaor, MD PhD · Clinical Hospital Center, Split
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2016-10-31
- Completion
- 2016-12-31
Countries
- Croatia
Study Locations
More Related Trials
-
A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery
NCT05528172 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery
NCT04711213 ·Status: COMPLETED ·Phase: PHASE2
-
Eye Surface Properties After Using Dexamethasone Drops With and Without Preservatives in Patients After Cataract Surgery
NCT05753787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort
NCT02506348 ·Status: UNKNOWN ·Phase: NA
-
PGE2 Levels in Patient Treated With NSAIDs
NCT03597867 ·Status: COMPLETED ·Phase: PHASE3
-
Protein Profile of Immunoregulatory Factors in Diabetic Cataract
NCT01832311 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
NCT01395069 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
NCT03687931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
NCT05626478 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
NCT04205916 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
NCT02973880 ·Status: COMPLETED ·Phase: PHASE3
-
Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery
NCT04316936 ·Status: COMPLETED ·Phase: PHASE4
-
Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery
NCT02558218 ·Status: COMPLETED ·Phase: NA
-
The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo
NCT03125785 ·Status: UNKNOWN
-
A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
NCT05826353 ·Status: COMPLETED ·Phase: PHASE3
-
"A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"
NCT04781335 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery
NCT02608489 ·Status: COMPLETED ·Phase: NA
-
The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy
NCT06969586 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy
NCT02955641 ·Status: UNKNOWN ·Phase: NA
-
No Drop Post-Op Cataract Surgery
NCT03864133 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
NCT00335439 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
NCT00198445 ·Status: COMPLETED ·Phase: PHASE3
-
Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects
NCT04324359 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
NCT04273282 ·Status: COMPLETED ·Phase: PHASE4
-
Study for Optimizing Anti-inflammatory Prophylaxis
NCT03383328 ·Status: COMPLETED ·Phase: PHASE4